| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 58,648 | 03 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | 01 Oct 2025 | 2 | $0 | 4 | Director | 03 Oct 2025, 19:14 |
| OTLK | Outlook Therapeutics, Inc. | 01 Oct 2024 | 3 | $0 | 4 | Director | 03 Oct 2024, 20:30 |
| OTLK | Outlook Therapeutics, Inc. | 07 Mar 2024 | 1 | $0 | 4 | Director | 08 Mar 2024, 16:14 |
| OTLK | Outlook Therapeutics, Inc. | 04 Oct 2023 | 1 | $0 | 4 | Director | 05 Oct 2023, 17:13 |
| OTLK | Outlook Therapeutics, Inc. | 29 Mar 2023 | 1 | $0 | 4 | Director | 31 Mar 2023, 17:47 |
| OTLK | Outlook Therapeutics, Inc. | 05 Oct 2022 | 1 | $0 | 4 | Director | 07 Oct 2022, 16:34 |
| OTLK | Outlook Therapeutics, Inc. | 23 Mar 2022 | 1 | $0 | 4 | Director | 24 Mar 2022, 17:38 |
| OTLK | Outlook Therapeutics, Inc. | 05 Oct 2021 | 1 | $0 | 4 | Director | 07 Oct 2021, 17:08 |